Scanis launches European office

Article

Mammography CAD developer Scanis is gearing up its global efforts in preparation for the launch of its Mammex TR system. The Foster City, CA-based firm has established a European marketing office in Eindhoven, the Netherlands. The office will be led by

Mammography CAD developer Scanis is gearing up its global efforts in preparation for the launch of its Mammex TR system. The Foster City, CA-based firm has established a European marketing office in Eindhoven, the Netherlands. The office will be led by Theo Spangenberg, who has been named European marketing director.

Scanis expects Mammex TR will be available in Europe in the first quarter. The unit has completed preclinical evaluation at the Norris Comprehensive Cancer Center at the University of Southern California (SCAN Special Report, January 2000), and was also recently installed at the Klinik Hirslanden in Zurich, Switzerland, where it will undergo further evaluation. Mammex TR was developed jointly with the TRW Center for Medical Image Analysis (SCAN 10/15/97).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.